Johnson & Johnson Aktie News

Deal would resolve tens of thousands of lawsuits alleging company's baby powder causes ovarian cancer

Johnson & Johnson JNJ, -1.52% unveiled its latest plan to settle ovarian cancer talc claims with the news of a consensual “prepackaged” reorganization of its LTL Management LLC unit, which manages the legal wrangling. The plan is expected to resolve 99.75% of all pending talc lawsuits against the company and its units in the U.S., it said in a statement.

Johnson & Johnson is moving forward with a $6.475 billion proposed settlement of tens of thousands of lawsuits alleging that its baby powder and other talc products contain asbestos and cause ovarian cancer, the company said Wednesday in a statement.

Johnson & Johnson will pay $6.5 billion to resolve nearly all talc ovarian cancer lawsuits in U.S.

NEW BRUNSWICK, N.J.--(BUSINESS WIRE)--Johnson & Johnson (NYSE: JNJ) (the “Company”) today announced a proposed Plan of Reorganization (the “Plan”) by its subsidiary, LLT Management LLC ("LLT"), for the comprehensive and final resolution of all current and future claims related to ovarian cancer arising from cosmetic talc litigation against it and its affiliates in the United States. “The Plan i...

The healthcare industry has experienced unprecedented growth in recent years due to the global pandemic. However, as COVID-19 began to ease, the immense growth of the healthcare industry is expected to slow down.

When the biggest names on Wall Street make an investment decision, the world listens. As the first quarter of 2024 comes to a close, SEC 13-F filings are coming in hot, showing investors where some of the biggest fund managers are finding investing opportunities despite market indexes hovering near all-time highs.

If you're searching for stocks to outperform the S&P 500, look no further. Some stocks are more solid than others against market downturns and macro-economic uncertainty and have high chances of beating the S&P 500 index.